Lost Ground: Cancer Screening in the COVID-19 Era
A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.
A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.
From - Diagnostic Testing & Emerging Technologies
Ambry Genetics (Aliso Viejo, Calif.) took a stance in the debate over sharing of genetic data this week. The genetic testing firm launched…
From - Diagnostic Testing & Emerging Technologies
The majority of U.K. clinical genetics services report that they recontact patients or family members about new findings relevant to…
From - Diagnostic Testing & Emerging Technologies
On the heels of last week's White House Precision Medicine Summit, new research findings suggest that a personalized approach can…
From - Diagnostic Testing & Emerging Technologies
Real-time genomic surveillance is possible in resource-limited settings to monitor infectious disease outbreaks, according to…
From - Diagnostic Testing & Emerging Technologies
Except for academic medical centers, few hospital executives see personalized medicine playing a significant role at their organization…